Silmaril
Prompt injection defense that is self-healing Status: Active. Batch: YC Spring 2026. HQ: San Francisco, CA, USA. Industry: B2B. https://silmaril.dev
Details
- cohort year
- 2026
- country
- United States
- exited
- false
- industry
- b2b
- one liner
- Prompt injection defense that self-improves
- status
- active
- team size
- 2
accelerator → invested in1
participated in → cohort1